Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Biotech Start-Up Specializes In Regenerating Skin

This article was originally published in PharmAsia News

Executive Summary

Japanese biotech Two Cells is specializing in regenerative medicine, beginning with plasters and artificial scalps made with regenerated skin cells. The research for the start-up, a spin-off of Hiroshima University, is being developed at Kobe University and other institutions. Two Cells' specialty has meant it is involved in cell culturing and non-medical products such as software. The scalp work involves using cultured epidermal cells attached to a biological plaster bandage to be placed over damaged skin to promote healing. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts